Copertina

Differences in the approach to guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction: A survey of cardiologists, internists, and pharmacists

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lana Alhashimi, David J. Cordwin, Jessica Guidi, Scott L. Hummel, Todd M. Koelling, Michael P. Dorsch
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Screening and treatment of iron deficiency among heart failure patients with impaired ejection fraction: The impact of a pharmacist‐led protocol
di: Jamila Alaryani, et al.
Pubblicazione: (2025)

The economic impact of the pharmacist in heart failure ambulatory care clinics: A scoping review
di: Justine Brasseur‐Masse, et al.
Pubblicazione: (2025)

Empowering pharmacists with data: Steps toward proactive medication safety and quality improvement
di: Lara K. Ellinger, et al.
Pubblicazione: (2024)

Impact of pharmacist‐led discharge medication reconciliation on error and patient harm prevention at a large academic medical center
di: Linda Zheng, et al.
Pubblicazione: (2024)

An analysis of the impact on total cost of care within a pharmacist‐led comprehensive medication management program
di: Julie Anne Earby, et al.
Pubblicazione: (2024)

Pharmacist certification of drug therapy modification: A survey of pharmacist‐reported practices, facilitators, and barriers in Georgia
di: Rebecca H. Stone, et al.
Pubblicazione: (2024)

Using a rule‐based decision tool for medication dose selection to improve patient safety and the need for pharmacist intervention
di: Tyler Finocchio, et al.
Pubblicazione: (2024)

Implementation of a pharmacist‐driven chronic obstructive pulmonary disease transitions of care service at a large academic medical center
di: Maggie M. Lycouras, et al.
Pubblicazione: (2024)

Evaluation of single maintenance and reliever therapy (SMART) prescribing of budesonide‐formoterol for asthma after a clinical pharmacist‐led initiative
di: Ila M. Harris, et al.
Pubblicazione: (2024)

Connecting medication therapy problems with social determinants of health: A proposed framework
di: Kylee A. Funk, et al.
Pubblicazione: (2024)

Comment on “Connecting medication therapy problems with social determinants of health: A proposed framework”
di: Sarah E. Vordenberg
Pubblicazione: (2024)

Age‐based transitions of care: Where is the pharmacist?
di: Sara W. Hovey, et al.
Pubblicazione: (2024)

Impact of internal medicine pharmacists on antimicrobial stewardship
di: Ashley Rizzo, et al.
Pubblicazione: (2024)

National survey of transplant pharmacist ambulatory care practices
di: Helen Sweiss, et al.
Pubblicazione: (2024)

Long‐term effect of pharmacist‐led interventions on diabetes distress
di: Shae L. Martel, et al.
Pubblicazione: (2025)

Unique model for pharmacist cross‐coverage in the ambulatory care setting
di: Anna Abrahamson, et al.
Pubblicazione: (2024)

Professional and career development needs of clinical pharmacists in settings outside academia
di: Sarah M. Hayes, et al.
Pubblicazione: (2024)

Nationwide evaluation of the clinical impact of acute care adult medicine pharmacists
di: Jennifer A. Szwak, et al.
Pubblicazione: (2024)

Trends and considerations for interprofessional continuing education activities for pharmacists and pharmacy technicians
di: Logan T. Murry, et al.
Pubblicazione: (2025)

Evaluation of oral targeted anticancer drug interactions and their management by oncology pharmacists
di: Sarah L. Wede, et al.
Pubblicazione: (2024)

Development and application of a toolkit for community pharmacist‐led review of patients with diabetes
di: Justine Borg, et al.
Pubblicazione: (2025)

Evaluation of a psychiatric pharmacist consultation service in a multispecialty outpatient clinic
di: Deni Hui, et al.
Pubblicazione: (2024)

Identifying ideal pharmacist‐to‐patient ratios for the successful provision of clinical pharmacy services
di: Jay L. Martello, et al.
Pubblicazione: (2024)

Comment on “Professional and career development needs of clinical pharmacists in settings outside academia”
di: G. Christina Gutierrez, et al.
Pubblicazione: (2024)

HIV pre‐exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States
di: Parya Saberi, et al.
Pubblicazione: (2024)

Remediation strategies for student pharmacists with socio‐behavioral issues in the experiential curriculum: A case series
di: Lindsey Dayer, et al.
Pubblicazione: (2024)

Impact of interprofessional and simulation activities on student pharmacists' professional identity formation: A qualitative study
di: Christina H. Sherrill, et al.
Pubblicazione: (2025)

Impact of pharmacist management on chronic obstructive pulmonary disease in a family medicine residency clinic
di: Jacqueline Elaine Figueras, et al.
Pubblicazione: (2025)

Evaluating practitioner attitudes toward pharmacist clinician prescribing of buprenorphine for the treatment of opioid use disorder
di: Miguel Lopez, et al.
Pubblicazione: (2025)

Retrospective cohort study of ambulatory care pharmacist interventions’ impact on incidence of therapeutic response in anxiety and depression
di: Ashlyn M. Kiebach, et al.
Pubblicazione: (2024)

State of the union: A review of state‐based laws and regulations supporting pharmacist payment for clinical services
Pubblicazione: (2024)

Building and testing a team‐based care model in primary care: The heart‐2‐heart blood pressure control partners study
di: Mollie Ashe Scott, et al.
Pubblicazione: (2025)

Evaluating the impact of pharmacist counseling on patient satisfaction and willingness to pay: A study in the Pakistan health care context
di: Asma Ghulam Mustafa, et al.
Pubblicazione: (2024)

EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA‐PHARMS): The clinical pharmacist's perspective
di: Christy Forehand, et al.
Pubblicazione: (2024)

Implementation of a pharmacist‐driven continuous glucose monitoring program within an American Indian/Alaska Native community
di: DeAnne L. Udby, et al.
Pubblicazione: (2025)

Comment on “Retrospective cohort study of ambulatory care pharmacist interventions' impact on incidence of therapeutic response in anxiety and depression”
di: Angeleki Zecopoulos, et al.
Pubblicazione: (2025)

Response to comment on “Restrospective cohort study of ambulatory care pharmacist interventions' impact on incidence of therapeutic response in anxiety and depression”
di: Ashlyn M. Kiebach, et al.
Pubblicazione: (2025)

Integrating clinical pharmacists into transitions of care: A qualitative study of barriers and facilitators among federally qualified health centers
di: Ben C. D. Weideman, et al.
Pubblicazione: (2024)

A tale of two bills: Lessons learned in expanding pharmacist‐led HIV pre‐exposure and post‐exposure prophylaxis
di: Jennifer Cocohoba, et al.
Pubblicazione: (2024)

Insights on antifungal therapeutic drug monitoring from infectious diseases physicians and hospital‐based pharmacists: A focus group analysis
di: Annie Cheung, et al.
Pubblicazione: (2025)